Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline. Plans to reduce the cost of medicines often target so-called PBMs as primary culprits behind the nation’s out-of-control drug prices.
But consumers often don’t notice or understand PBMs and how they factor into determining costs at the pharmacy counter. This , brought out from our vault, details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to treatments.
For more information on drug pricing issues, check out this chart and these videos:
This KHN story also ran on . It can be republished for free (details).KHN also offers other videos examining hot topics such as , , and how the health law could be disassembled through the .
ºÚÁϳԹÏÍø News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about .Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.
